Bruker Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BRKRP | BIO | 49Z.F | BMRA | PACB | NCYT.L | |
|---|---|---|---|---|---|---|
| Market cap | — | 9.86B | 154.56M | 7.47M | 774.06M | 24.88M |
| P/E (TTM) | — | 46.7 | — | — | — | — |
| Forward P/E | — | 37.8 | — | 4.2 | -5.9 | -4.9 |
| Price/book | 29.7 | 1.3 | 0.1 | 2.0 | 138.4 | 1.3 |
| Dividend yield | 3.84% | — | — | — | — | — |
| 1-year change | +29.06% | +23.96% | +7.89% | −31.76% | +43.26% | −10.05% |
| Today | +11.95% | −2.93% | +3.30% | −6.34% | −2.34% | −4.19% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All BRKRP news ›Bruker expects FY 2026 non-GAAP EPS of $2.10-$2.15 while targeting 250-300 bps operating margin expansion
Bruker Q3 2026 earnings: margins and EPS beat, China bookings rebound, and 2027 semi demand builds. Earnings Call Insights: Bruker (BRKR) Q3 2026 - "Bruker's positive bookings trends continued in the fifth consecutive quarter of Bruker…
Bruker Reports Third Quarter 2026 Financial Results
Nov 4, 2026 7:00am EST BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and nine months ended September 30, 2026. Third Quarter 2026 (Q3-26) Financial Results Bruker’s…
Bruker Corporation (BRKR) Q3 2026 Earnings Call Transcript
Bruker Corporation (BRKR) Q3 2026 Earnings Call November 4, 2026 8:30 AM ESTCompany ParticipantsJoe KostkaFrank Laukien - Chairman, CEO &... Bruker Corporation (BRKR) Q3 2026 Earnings Call November 4, 2026 8:30 AM EST Puneet Souda -…
More from 1 other outlet
Bruker Reports 2 Percent Q3 Revenue Rises, Lowers 2026 Guidance
Bruker Reports 2 Percent Q3 Revenue Rise, Lowers 2026 Revenue Guidance GenomeWeb Bruker Reports 2 Percent Q3 Revenue Rise, Lowers 2026 Revenue Guidance
Bruker Q3 Earnings Call Highlights
Posted by Mitch Edgeman on Nov 4th, 2026 Bruker (NASDAQ:BRKR) reported third-quarter 2026 revenue growth of 1.6% to $874 million, while non-GAAP earnings per share rose 24.4% year over year to $0.56 as cost-saving actions and favorable…
Bruker (NASDAQ:BRKR) surprises with Q3 2026 sales, stock soars
Scientific instrument company Bruker (NASDAQ:BRKR) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 1.6% year on year to $874 million. The company expects the full year’s revenue to be around $3.54…
Bruker Drops 9.5% Amid Sector-Wide Selling
Bruker Corporation plunged 9.5% on Friday, closing at $56.13 as a broad selloff hammered medical device sector peers across the board. The $8.6 billion comp... The post Bruker Drops 9.5% Amid Sector-Wide Selling first appeared on…
Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast
BioSpace Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter
Bruker, Sotera downgraded as J.P. Morgan reviews life sciences coverage
Bruker, Sotera downgraded at J.P. Morgan (BRKR:NASDAQ) Seeking Alpha J.P. Morgan downgraded Bruker Corporation (BRKR) and Sotera Health (SHC) on Wednesday as the brokerage reviewed its coverage of the life science tools & diagnostics space…
Bruker (NASDAQ:BRKR) Stock Keeps Neutral Rating at JPMorgan Chase & Co.
MarketBeat Bruker (NASDAQ:BRKR) Stock Keeps Neutral Rating at JPMorgan Chase & Co. - JPMorgan reaffirmed its “neutral” rating on Bruker and maintained a $60 price target, implying approximately 6.78% upside from the stock’s $56.
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketbeat.com3
- seekingalpha.com3
- themarketsdaily.com2
- tradingview.com2
- biospace.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.